GAS5 and nasopharyngeal carcinoma: Our previous findings have suggested NPC patients with lncRNA GAS5 rs2067079 CT genotypes were linked with an obviously increased risk of severe myelosuppression during concurrent radiochemotherapy period compared with CC genotype carriers (Guo et al., 2017).